Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by m8magic on Oct 30, 2024 4:38pm

ps..

i think we have found our
Comment by m8magic on Oct 30, 2024 5:07pm
i think we have found our bottem hopefully...and news soon
Comment by chry200030 on Oct 30, 2024 6:20pm
I think you're right... the bottom is IN. We will get confirmation tomorrow... Expect a nice day tomorrow if we get liftoff...
Comment by DeathXray33 on Oct 30, 2024 8:50pm
"AbbVie buying all the outstanding shares of Aliada Therapeutics for $1.4 billion in cash. A private company, Aliada formed in 2021 with seed funding from J&Js venture arm" - "Aliada has a license to a technology J&J scientists created to get drugs across a kind of biological shield that protects the central nervous system. This blood-brain barrier is extremely selective ...more  
Comment by riverrrow on Oct 30, 2024 9:42pm
$1.4 billion for tools which I'm guessing are a long way and many years  from FDA approval for clinical use.
Comment by DeathXray33 on Oct 30, 2024 8:58pm
"Rutherrin has been proven preclinically to be activated by Metformin, a common diabetes drug, without the use of light and/or radiation. Even more interesting is that because Rutherrin and Metformin are both scientifically proven to cross the blood-brain barrier, as well as tumour-specific blood barriers, this new discovery potentially allows the precise targeting of cancer cells by ...more  
Comment by Infinity on Oct 31, 2024 6:53am
Hopefully RDW has lined up some treats for TLT investors.  Pull that BTD out!
Comment by Feedman2980 on Oct 31, 2024 7:52am
We need a good news release. Maybe they have sent in BTD application. Once we do stock price should respond positively
Comment by DJDawg on Oct 31, 2024 11:47am
My hunch is that they may not release any news till the PP closes Nov 8. Sometimes there are rules around releasing info during a capital raise. Not 100% sure.
Comment by menoalittle on Oct 31, 2024 1:09pm
Hmmm... Sounds like a good bit more than a hunch to me...
Comment by chry200030 on Oct 31, 2024 1:51pm
Which PP is that which will close Nov 08? This is the last PP mentioned and it is closed. 2024-09-24 17:20 ET - News Release Theralase Technologies Inc. has successfully closed a non-brokered private placement (NBPP) offering of units. On closing, the corporation issued an aggregate of 2.72 million units at a price of 20 cents per unit for aggregate gross proceeds of $544,000.
Comment by DJDawg on Oct 31, 2024 2:25pm
There have been copies circulating. MP sent a PP announcement email Oct 25 for small raise. It was copy paste here or on ceo.ca website. Most of the PP's that they have done in the past close two weeks out so Oct 25 + 2 weeks suggest Nov 8 or Nov 12(Nov 11 is holiday). Unless they set some other deadline. Who knows.
Comment by rollthedice10 on Oct 31, 2024 2:48pm
I often wonder why they don't go for bigger PPs. To me, frequent PPS are bad optics, but that's just my opinion. Then again, there are some deeper pocketed investors who welcome PP offerings as the terms are usually in the favour of the investor. In any case, it is only some news with a bit of meat on it that will drive the SP higher ( possibly a lot higher ). This in turn will catch the ...more  
Comment by IainCaimbeul on Oct 31, 2024 4:18pm
Bigger pps, maybe because the lenders don't trust them, don't like the sp, don't like the management etc. "This could be HUGE". Jeez I tried that line with the ladies when I was younger, still awaiting a response from some. ;) An example SZLS - has not been able to pay the auditors for ye 2023 fins, we are now in q4 2024 and the bill is still outstanding. They have a $25m ...more  
Comment by Oilminerdeluxe on Oct 31, 2024 4:34pm
You should not try and compare those companies. Bad Mojo. There are many, billions waiting for TLT when the day is right. Just need to get there. Also, a whole lot more people are willing to support it in the mean time. If we get BTD in Q1, or sooner, things will be so much different. 
Comment by Longholder99 on Oct 31, 2024 4:52pm
Any big dog watching and waiting to invest in a disruptor oncology company doesn't care if the sp is .25 or 2.50.  They also don't care what bashers on an anonymous internet message board think.   They do their own DD.....talk to the world renowned Doctors conducting and supervising the tests.   Then they move in when their Board says Go.   On that day ...more  
Comment by wildbird1 on Oct 31, 2024 2:06pm
In this link...Page 3...Microsoft Word - NP40.doc About Material information. It said '' An issuer(TLT) is required to disclose material information concerning its business and affairs forthwith upon the information becoming know to management....''. Now the question is, does TLT consider that receiving the green light from the FDA to proceed for the BTD application '' ...more  
Comment by BlueFranky on Oct 31, 2024 2:17pm
Perhaps another question might be: do TLT lawyers consider news from the FDA on a pre-BTD application to be legally material and if not for instance, would it be more advantageous to release said "non-essential" news before or after a PP? It would also be interesting to know what other applicants have done with pre-BTD news insofar as dissemination (or not) to shareholders?
Comment by Alamir1111 on Oct 31, 2024 2:27pm
What's the sense of announcing applying for pre btd and not giving update on process ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250